(RTTNews) - Cingulate (CING) announced that it has received formal pre-New Drug Application meeting minutes from the FDA for its lead asset CTx-1301 for the treatment of Attention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback